HIF1A and neoplasm: However, 30–40% of clinically diagnosed ccRCC lack the expression of HIF-1α, suggesting that HIF-1α may act as a tumour suppressor gene in those scenarios where its expression may be mandatory for initial development but lost as the tumour progresses [16].